134 related articles for article (PubMed ID: 16045858)
1. The effects of long term use of inhaled corticosteroids on linear growth, adrenal function and bone mineral density in children.
Altintas DU; Karakoc GB; Can S; Yilmaz M; Kendirli SG
Allergol Immunopathol (Madr); 2005; 33(4):204-9. PubMed ID: 16045858
[TBL] [Abstract][Full Text] [Related]
2. Adrenal function in children with severe asthma treated with high-dose inhaled glucocorticoids: recommended screening tests in outpatient conditions.
Breborowicz A; Niedziela M
J Pediatr Endocrinol Metab; 2007 Jul; 20(7):781-9. PubMed ID: 17849740
[TBL] [Abstract][Full Text] [Related]
3. Safety of inhaled fluticasone propionate therapy for pediatric asthma - a systematic review.
Muley P; Shah M; Muley A
Curr Drug Saf; 2013 Jul; 8(3):186-94. PubMed ID: 23859431
[TBL] [Abstract][Full Text] [Related]
4. Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids.
Kannisto S; Korppi M; Remes K; Voutilainen R
J Clin Endocrinol Metab; 2000 Feb; 85(2):652-7. PubMed ID: 10690871
[TBL] [Abstract][Full Text] [Related]
5. One year prospective open study of the effect of high dose inhaled steroids, fluticasone propionate, and budesonide on bone markers and bone mineral density.
Hughes JA; Conry BG; Male SM; Eastell R
Thorax; 1999 Mar; 54(3):223-9. PubMed ID: 10325897
[TBL] [Abstract][Full Text] [Related]
6. Fluticasone propionate and budesonide do not influence bone metabolism in the long term treatment of asthma.
Harmanci E; Colak O; Metintas M; Alatas O; Yurdasiper A
Allergol Immunopathol (Madr); 2001; 29(1):22-7. PubMed ID: 11449531
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide.
Ferguson AC; Spier S; Manjra A; Versteegh FG; Mark S; Zhang P
J Pediatr; 1999 Apr; 134(4):422-7. PubMed ID: 10190915
[TBL] [Abstract][Full Text] [Related]
8. The comparison of the effects of fluticasone propionate and budesonide on clinical indices and on bone mineral density in the asthmatic patients: a one year treatment study.
Harmanci E; Ak I; Ozdemir N; Vardareli E; Elbek O; Uçgun I
Allergol Immunopathol (Madr); 1999; 27(6):298-303. PubMed ID: 10611554
[TBL] [Abstract][Full Text] [Related]
9. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
Lipworth BJ; Clark DJ; McFarlane LC
Thorax; 1997 Aug; 52(8):686-9. PubMed ID: 9337826
[TBL] [Abstract][Full Text] [Related]
10. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids.
Hanania NA; Chapman KR; Sturtridge WC; Szalai JP; Kesten S
J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):571-9. PubMed ID: 7499672
[TBL] [Abstract][Full Text] [Related]
11. Effects of inhaled corticosteroids on growth in asthmatic children: a comparison of fluticasone propionate with budesonide.
Acun C; Tomac N; Ermis B; Onk G
Allergy Asthma Proc; 2005; 26(3):204-6. PubMed ID: 16119035
[TBL] [Abstract][Full Text] [Related]
12. Ciclesonide versus other inhaled corticosteroids for chronic asthma in children.
Kramer S; Rottier BL; Scholten RJ; Boluyt N
Cochrane Database Syst Rev; 2013 Feb; (2):CD010352. PubMed ID: 23450613
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.
Harrison TW; Wisniewski A; Honour J; Tattersfield AE
Thorax; 2001 Mar; 56(3):186-91. PubMed ID: 11182010
[TBL] [Abstract][Full Text] [Related]
14. Osteocalcin, cortisol levels, and bone mineral density in prepubertal children with asthma treated with long-term fluticasone propionate.
Ozkaya E; Nursoy MA; Uzuner S; Erenberk U; Çakır E
Horm Res Paediatr; 2012; 77(6):351-7. PubMed ID: 22760032
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the relative growth velocities with budesonide and fluticasone propionate in children with asthma.
Ferguson AC; Van Bever HP; Teper AM; Lasytsya O; Goldfrad CH; Whitehead PJ
Respir Med; 2007 Jan; 101(1):118-29. PubMed ID: 16735113
[TBL] [Abstract][Full Text] [Related]
16. Nebulized fluticasone propionate vs. budesonide as adjunctive treatment in children with asthma exacerbation.
De Benedictis FM; Del Giudice MM; Vetrella M; Tressanti F; Tronci A; Testi R; Dasic G;
J Asthma; 2005 Jun; 42(5):331-6. PubMed ID: 16116682
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, double-dummy, parallel-group, multicenter, dose-reduction trial of the minimal effective doses of budesonide and fluticasone dry-powder inhalers in adults with mild to moderate asthma.
Kuna P; Joubert JR; Greefhorst LA; Magnussen H
Clin Ther; 2003 Aug; 25(8):2182-97. PubMed ID: 14512127
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function.
Nielsen LP; Dahl R
Am J Respir Crit Care Med; 2000 Dec; 162(6):2053-7. PubMed ID: 11112113
[TBL] [Abstract][Full Text] [Related]
19. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review.
Dyer MJ; Halpin DM; Stein K
BMC Fam Pract; 2006 Jun; 7():34. PubMed ID: 16753053
[TBL] [Abstract][Full Text] [Related]
20. Systemic activity of inhaled corticosteroid treatment in asthmatic children: corticotrophin releasing hormone test.
Pescollderungg L; Radetti G; Gottardi E; Peroni DG; Pietrobelli A; Boner AL
Thorax; 2003 Mar; 58(3):227-30. PubMed ID: 12612299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
